Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atricure Inc (NQ: ATRC )

77.67 USD -0.04 (-0.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 246,599
Open 77.01
Bid (Size) 71.64 (1)
Ask (Size) 77.86 (13)
Prev. Close 77.71
Today's Range 77.01 - 80.44
52wk Range 34.04 - 80.44
Shares Outstanding 45,629,462
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced U.S. Food and Drug Administration (FDA)... 
From Business Wire News Releases
AtriCure Reports First Quarter 2021 Financial Results
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2021 financial results. 
From Business Wire News Releases

Performance

YTD
+44.39%
+44.39%
1 Month
+19.66%
+19.66%
3 Month
+30.01%
+30.01%
6 Month
+111.58%
+111.58%
1 Year
+85.64%
+85.64%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Tags NMRD SELB ADVM
From Benzinga
Here's Why AtriCure Stock Is Moving Today
Tags Benzinga Analyst Ratings Earnings
From Benzinga
AtriCure: Q1 Earnings Insights
Tags Market News ATRC Benzinga
From Benzinga
AtriCure Names B. Kristine Johnson Board Chair
From Business Wire News Releases
Stocks Showing Rising Market Leadership: Atricure Earns 81 RS Rating
From Investor's Business Daily
Preview: AtriCure's Earnings
Tags BZI/EP Benzinga Earnings
From Benzinga
AtriCure Inc (ATRC) Q1 2021 Earnings Call Transcript
Tags Market News ATRC
From Motley Fool
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Tags News DYAI MDGL
From Benzinga
65 Biggest Movers From Yesterday
Tags DLPN CDE RLGY
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.